27.46
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.80%
243.78
|
239.46 | 200.49 | 184.73 | 201.27 |
| Cost Of Revenue |
14.91%
68.55
|
59.65 | 38.15 | 31.99 | 54.41 |
| Gross Profit |
2.54%
175.23
|
179.81 | 162.34 | 152.74 | 146.86 |
|
|
19.56%
136.67
|
114.32 | 114.16 | 96.49 | 91.13 |
| Benefits Costs and Expenses |
18.06%
203.02
|
171.97 | 150.85 | 127.56 | 145.11 |
| Costs And Expenses |
18.06%
203.02
|
171.97 | 150.85 | 127.56 | 145.11 |
| Operating Income/Loss |
41.12%
38.56
|
65.49 | 48.18 | 56.24 | 55.73 |
| Income/Loss From Continuing Operations Before Tax |
39.61%
40.76
|
67.49 | 49.64 | 57.18 | 56.16 |
| Income Tax Expense/Benefit |
9.92%
18.27
|
16.62 | 9.861 | 11.62 | 6.68 |
| Income/Loss From Continuing Operations After Tax |
55.79%
22.49
|
50.87 | 39.78 | 45.56 | 49.48 |
|
|
55.79%
22.49
|
50.87 | 39.78 | 45.56 | 49.48 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.28%
-0.163
|
57.55 | 57.47 | 57.31 | 0.0703 |
| Diluted Average Shares |
100.33%
-0.1938
|
58.72 | 58.43 | 58.52 | 0.1159 |
| Basic Earnings Per Share |
54.55%
0.40
|
0.88 | 0.69 | 0.79 | 0.87 |
| Diluted Earnings Per Share |
55.17%
0.39
|
0.87 | 0.68 | 0.78 | 0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):